T1	Participants 84 107	advanced breast cancer:
T2	Participants 147 248	From January 1985 to September 1988, 60 women with advanced breast cancer were randomized in two arms
T3	Participants 485 677	All patients were post-menopausal, previously untreated with hormone therapy, and with tumor receptor status determined immediately before randomization; all had objectively evaluable lesions.
T4	Participants 833 903	Thirty-one and 29 patients were included respectively in arms A and B.
